Open original FDA record ↗Recall record
- FDA identifier
- Z-2210-2023
- Company in FDA record
- Cytocell Ltd.
- FDA classification date
- Jul 20, 2023
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
DNAs used during the manufacture of two affected models were accidentally inverted during manufacturing.
Source facts
- Action
- Customers were sent a recall notification dated 05/24/2023 informing them of this recall event. Customers are asked to identify any affected devices in stock and quarantine any devices from recalled lots. Affected devices are to be destroyed by customers. Additionally, customers are encouraged to review results obtained utilized affected devices to ensure that no results were misinterpreted due to the incorrect labeling of the DNA. Customers are to return the provided response form by fax to +44(0)1223294048 or by email to vigilance@ogt.com. Customers with any questions can contact Cytocell by phone at +44(0)1223294048, by fax at +44(0)1223294986, or by email at vigilance@ogt.com.
- Initiated
- 2023-05-24
- Root cause
- Process control
- Distribution
- US Nationwide distribution in the states of CA, FL, OH, & SC.
- Recall number
- Z-2210-2023
- Recall status
- Open, Classified
- CDRH record ID
- 201783
- FDA classified
- 2023-07-20
- Recall event number
- 92586